Diagnosis and treatment of chronic insomnia

Annals of Indian Academy of Neurology

Volumn 13, Issue 2, 2010, Pages 94-102

  Saddichha, Sahoo ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Chronic; diagnosis; insomnia; treatment

Indexed keywords

AMITRIPTYLINE; ANTIHISTAMINIC AGENT; BENZODIAZEPINE; ESZOPICLONE; RAMELTEON; TRAZODONE; ZALEPLON; ZOLPIDEM; ZOPICLONE;

ACTIMETRY; BEHAVIOR THERAPY; CHRONIC DISEASE; COGNITIVE THERAPY; EPWORTH SLEEPINESS SCALE; INSOMNIA; MEDLINE; PATIENT EDUCATION; POLYSOMNOGRAPHY; RELAXATION TRAINING; REVIEW; SLEEP THERAPY;

EID: 77954222302     PISSN: 09722327     EISSN: 19983549     Source Type: Journal    
DOI: 10.4103/0972-2327.64628     Document Type: Review

References (68)

1. Mellinger GD, Balter MB, Uhlenhuth EH. Insomnia and its treatment. Prevalence and correlates. Arch Gen Psychiatry 1985;42:225-232
2. Carney PR, Berry RB, Geyer JD. Insomnia: Causes and treatment. Clinical Sleep Disorders. Philadelphia: Lippincott William and Wilkins; 2005. p. 157-191
3. Ancoli-Israel S, Roth T. Characteristics of insomnia in the United States: Results of the 1991 National Sleep Foundation Survey. I. Sleep 1999;22:S347-53 (Pubitemid 29293494)
4. Roth T. New developments for treating sleep disorders. J Clin Psychiatry 2001;62:3-4
5. Dollander M. Etiology of adult insomnia. Encephale 2002;28: 493-502
6. Hohagen F, Rink K, Käppler C, Schramm E, Rieman D, Weyerer S, et al. Prevalence and treatment of insomnia in general practice: A longitudinal study. Eur Arch Psych Clin Neurosc 1993;242:325-336
7. Riedel BW, Durrence HH, Lichstein KL, Taylor DJ, Bush AJ. The relation between smoking and sleep: The influence of smoking level, health, and psychological variables. Behav Sleep Med 2004;2:63-78
8. Buscemi N, Vandermeer B, Friesen C, Bialy L, Tubman M, Ospina M, et al. Manifestations and management of chronic insomnia in adults. Evid Rep Technol Assess (Summ) 2005;125:1-10
9. Benca RM. Diagnosis and treatment of chronic insomnia: A review. Psychiatr Serv 2005;56:332-343
10. Franzen PL, Buysse DJ. Sleep disturbances and depression: Risk relationships for subsequent depression and therapeutic implications. Dialogues Clin Neurosci 2008;10:473-481
11. Morin CM, LeBlanc M, Daley M, Gregoire JP, Merette C. Epidemiology of insomnia: Prevalence, self-help treatments, consul tations, and determinants of help-seeking behaviors. Sleep Med 2006;7: 123-130
12. Leger D, Guilleminault C, Bader G, Levy E, Paillard M. Medical and socio-professional impact of insomnia. Sleep 2002;25:625-629
13. Léger D, Massuel MA, Metlaine A; SISYPHE Study Group. Professional correlates of insomnia. Sleep 2006;29:171-178
14. Taylor DJ, Lichstein KL, Durrence HH. Insomnia as a health risk factor. Behav Sleep Med 2003;1:227-247
15. National Institute for Clinical Excellence (NICE) guidelines Manual- Chapter 7: Reviewing and grading the evidence (2007). Available from: http://www.nice.org.uk [last cited on 2009 Nov 21]
16. Rajput V, Bromley SM. Chronic insomnia: A practical review. Am Fam Physician 1999;60:1431-8; discussion 1441-1442
17. Sateia MJ, Nowell PD. Insomnia. Lancet 2004;364:1959-1973
18. Gillin JC. Psychiatric disorder. In: Kryger MH, Roth T, Dement WC, editors. Principle and practice of sleep medicine. 3rd ed. Philadelphia: W.B. Saunders; 2000
19. Buysse DJ, Ancoli-Israel S, Edinger JD, Lichstein KL, Morin CM. Recommendations for a standard research assessment of insomnia. Sleep 2006;29:1155-1173
20. Insomnia: Assessment and management in primary care. National Heart, Lung, and Blood Institute Working Group on Insomnia. Am Fam Physician 1999;59:3029-3038
21. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14:540-545
22. Krystal AD, Edinger JD, Wohlgemuth WK, Marsh GR. NREM sleep EEG frequency spectral correlates of sleep complaints in primary insomnia subtypes. Sleep 2002;25:630-640
23. Todd Arnedt J, Conroy D, Aloia M. Evaluation of insomnia patients. Sleep Med Clin 2006;1:319-332
24. Perlis ML, Merica H, Smith MT, Giles DE. Beta EEG activity and insomnia. Sleep Med Rev 2001;5:363-374
25. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Text Revision (DSM IV TR). 4th ed. Washington, DC: American Psychiatric Press; 2000
26. American Academy of Sleep Medicine. The international classification of sleep disorders: Diagnostic and coding manual, ICSD-2. 2nd ed. Westchester, IL: American Academy of Sleep Medicine; 2005
27. Chesson Jr. AL, Anderson WM, Littner M, Davila D, Hartse K, Johnson S, et al. Practice param eters for the non-pharmacologic treatment of chronic insomnia. An American Academy of Sleep Medicine report. Standards of Practice Committee of the American Academy of Sleep Medi cine. Sleep 1999;22:1128-1133
28. Morin CM, Hauri PJ, Espie CA, Spielman AJ, Buysse DJ, Bootzin RR. Nonpharmacologic treatment of chronic insomnia. An American Academy of Sleep Medicine review. Sleep 1999;22:1134-1156
29. Bootzin RR, Epstein D, Wood JM. Stimulus control instructions. In: Hauri P, editor. Case studies in insomnia. New York: Plenum Press; 1991. p. 19-28
30. Joshi S. Nonpharmacologic therapy for insomnia in the elderly. Clin Geriatr Med 2008;24:107-119
31. Morin CM, Culbert JP, Schwartz SM. Nonpharmacological interventions for insomnia: A meta-analysis of treatment efficacy. Am J Psychiatry 1994;151:1172-1180
32. Murtagh DR, Greenwood KM. Identifying effective psychological treatments for insomnia: A meta-analysis. J Consult Clin Psychol 1995;63:79-89
33. Lichstein KL. Relaxation. In K. L. Lichstein & C. M. Morin (Eds.), Treatment of late-life insomniae. Thousand Oaks, CA: Sage.; 2000. p. 297-319
34. Engle-Friedman M, Bootzin RR, Hazlewood L, Tsao C. An evaluation of behavioral treatments for insomnia in the older adult. J Clin Psychol 1992;48:77-90
35. Morin CM, Kowatch RA, Barry T, Walton E. Cognitive-behavior therapy for late-life insomnia. J Consult Clin Psychol 1993;61: 137-146
36. Hauri P, Linde S. No more sleepless nights. New York: John Wiley and Sons; 1990
37. Spielman AJ, Caruso LS, Glovinsky PB. A behavioral perspective on insomnia treatment. Psychiatr Clin North Am 1987;10:541-553
38. Lacks P, Rotert M. Knowledge and practice of sleep hygiene techniques in insomniacs and good sleepers. Behav Res Ther 1986;24:365-368
39. Pallesen S, Nordhus IH, Kvale G. Non-pharmacological interventions for insomnia in older adults: A meta-analysis of treatment efficacy. Psychother Theory Res Pract Train 1998;35:472-481
40. Irwin MR, Cole JC, Nicassio PM. Comparative meta-analysis of behavioral interventions for insomnia and their efficacy in middleaged adults and in older adults 55+ years of age. Health Psychol 2006;25:3-14
41. Montgomery P, Dennis J. A systematic review of nonpharmacological therapies for sleep problems in later life. Sleep Med Rev 2004;8:47-62
42. Riemann D, Perlis ML. The treatments of chronic insomnia: A review of benzodiazepine receptor agonists and psychological and behavioral therapies. Sleep Med Rev 2009;13:205-214
43. Kupfer DJ, Reynolds III CF. Management of insomnia. N Engl J Med 1997;336:341-346
44. Schutte-Rodin S, Broch L, Buysse D, Dorsey C, Sateia M. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med 2008;4:487-504
45. Lader M. Benzodiazepines: A risk benefit profile. CNS Drugs 1994;1:377-378
46. Lemmer B. The sleep-wake cycle and sleeping pills. Physiol Behav 2007;90:285-293
47. Holm KJ, Goa KL. Zolpidem: An update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia. Drugs 2000;59:865-889
48. Kamel NS, Gammack JK. Insomnia in the elderly: Cause, approach, and treatment. Am J Med 2006;119:463-469
49. Halas CJ. Eszopiclone. Am J Health Syst Pharm 2006;63:41-48
50. Kripke DF. Who should sponsor sleep disorders pharmaceutical trials? J Clin Sleep Med 2007;3:671-673
51. Roth T, Stubbs C, Walsh JK. Ramelteon (TAK-375), a selective MT1/MT2-receptor agonist, reduces latency to persistant sleep in a model of transient insomnia related to a novel sleep environment. Sleep 2005;28:303-307
52. Holbrook AM, Crowther R, Lotter A, Cheng C, King D. Metaanalysis of benzodiazepine use in the treatment of insomnia. CMAJ 2000;162:225-233
53. Holbrook A, Crowther R, Lotter A, Endeshaw Y. The role of ben zodiazepines in the treatment of insomnia: Meta-analysis of ben zodiazepine use in the treatment of insomnia. J Am Geriatr Soc 2001;49:824-826
54. Erman M, Seiden D, Zammit G, Sainati S, Zhang J. An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia. Sleep Med 2006;7:17-24
55. Barbera J, Shapiro C. Benefit-risk assessment of zaleplon in the treatment of insomnia. Drug Saf 2005;28:301-318
56. Winokur A, Reynolds CF. The effects of antidepressants on sleep physiology. Prim Psych 1994;1:22-27
57. Tariq SH, Pulisetty S. Pharmacotherapy for insomnia. Clin Geriatr Med 2008;24:93-105
58. Mendelson WB. A review of the evidence for the efficacy and safe ty of trazodone in insomnia. J Clin Psychiatry 2005;66:469-476
59. Winokur A, De Martinis III NA, McNally DP, Gary EM, Cormier JL, Gary KA. Comparative effects of mirtazapine and fluoxetine on sleep physiology measures in patients with major depression and insomnia. J Clin Psychiatry 2003;64:1224-1229
60. Riemann D, Voderholzer U, Cohrs S, Rodenbeck A, Hajak G, Rüther E, et al. Trimipramine in primary insomnia: Results of a polysomnographic double-blind con trolled study. Pharmacopsychiatry 2002;35:165-174
61. Hajak G, Rodenbeck A, Voderholzer U, Riemann D, Cohrs S, Hohagen F, et al. Doxepin in the treatment of primary insomnia: A placebo-controlled, double-blind, polysomnographic study. J Clin Psychiatry 2001;62:453-463
62. Morin CM, Koetter U, Bastien C, Ware JC, Wooten V. Vale rianhops combination and diphenhydramine for treating in somnia: A randomized placebo-controlled clinical trial. Sleep 2005;28: 1465-1471
63. Donath F, Quispe S, Diefenbach K, Maurer A, Fietze I, Roots I. Critical evaluation of the effect of valerian extract on sleep structure and sleep quality. Pharmacopsychiatry 2000;33:47-53
64. Bent S, Padula A, Moore D, Patterson M, Mehling W. Valerian for sleep: A systematic review and meta-analysis. Am J Med 2006;119:1005-1012
65. Schultz V, Hansel R, Tyler VE. Restless and sleep disturbances. In: Schultz V, Hansel R, Tyler VE. Rational Phytotherapy: A Physician's Guide to Herbal Medicine. 3rd ed. Berlin: Springer- Verlag; 1998. p. 73-88
66. Meolie AL, Rosen C, Kristo D, Kohrman M, Gooneratne N, Aguillard RN, et al. Oral nonprescription treatment for insomnia: An evaluation of products with limited evidence. J Clin Sleep Med 2005;1:173-187
67. Brzezinski A, Vangel MG, Wurtman RJ, Norrie G, Zhdanova I, Ben-Shushan A, et al. Effects of ex ogenous melatonin on sleep: A meta-analysis. Sleep Med Rev 2005;9:41-50
68. Farber R, Scharf MB, Black J, Landin R. Long-term nightly treatment with indiplon in adults with chronic insomnia: Results of a double-blind, placebo-controlled, 3-month study. Neurology 2006;66:A9